Sibylle Loibl

机构：Goethe University Frankfurt, Cardiovascular Center Bethanien, German Breast Group · ORCID：0000-0001-6488-4958

发表论文 128 篇 · 总被引 2337 次 · h-index 21

代表论文

• Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial (2024 · New England Journal of Medicine · 被引 307)
• Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer (2024 · New England Journal of Medicine · 被引 279)
• Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer (2025 · New England Journal of Medicine · 被引 102)
• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 52)
• Abstract GS1-09: OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancer: (2025 · Clinical Cancer Research · 被引 27)
• TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 24)